EOLS

Evolus, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD6.03

-0.14 (-2.27%)

Rating:C

Company Profile

CEO

David Moatazedi

IPO Date

2018-02-08

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

Market Metrics

Open

$6.16

Prev. Close

$6.17

Day Low

$5.95

Day High

$6.16

52W Low

$3.86

52W High

$10.62

Market Cap

$0.40B

Volume

0.50M

News SentimentBullish

Articles

Avg Positive

34.7%

Avg Negative

8.8%

Avg Neutral

56.8%

News Feed

Evolus, Inc. (EOLS) CEO David Moatazedi on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·8/4/2021·↓ negative

Evolus, Inc. (EOLS) Reports Q2 Loss, Tops Revenue Estimates

Zacks Investment Research·8/4/2021·↑ positive

Evolus Reports Second Quarter 2021 Results and Provides Business Update

GlobeNewsWire·8/4/2021·↑ positive